Overview

SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer

Status:
Not yet recruiting
Trial end date:
2027-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to find out how safe and effective is treating patients with locally advanced rectal cancer (LARC) with chemotherapy first and then follow with radiation therapy to a higher dose than what is usually delivered and see if patients could have complete response and be spared from surgery.
Phase:
Phase 1
Details
Lead Sponsor:
University of Miami
Treatments:
Capecitabine
Fluorouracil
Leucovorin
Oxaliplatin